{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T23:23:54Z","timestamp":1745018634261},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/jcp.0b013e31824888a1","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T09:40:25Z","timestamp":1330076425000},"page":"207-217","source":"Crossref","is-referenced-by-count":25,"title":["Computational Prediction of State Anxiety in Asian Patients With Cancer Susceptible to Chemotherapy-Induced Nausea and Vomiting"],"prefix":"10.1097","volume":"32","author":[{"given":"Kevin Yi-Lwern","family":"Yap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu Hui","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Keung","family":"Chui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00024669-200302010-00002","article-title":". Treatment options for chemotherapy-induced nausea and vomiting: current and future.","volume":"2","author":"Stieler","year":"2003","journal-title":"Am J Cancer"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00520-001-0321-4","article-title":". Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients.","volume":"10","author":"Molassiotis","year":"2002","journal-title":"Support Care Cancer"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1345\/aph.1L437","article-title":"Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.","volume":"43","author":"Shih","year":"2009","journal-title":"Ann Pharmacother"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/1097-0142(19890901)64:5<1117::AID-CNCR2820640525>3.0.CO;2-R","article-title":"Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model.","volume":"64","author":"Pollera","year":"1989","journal-title":"Cancer"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1634\/theoncologist.4-3-191","article-title":"Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.","volume":"4","author":"Hesketh","year":"1999","journal-title":"Oncologist"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/PPO.0b013e31816a0f07","article-title":"Chemotherapy-induced nausea and vomiting.","volume":"14","author":"Lohr","year":"2008","journal-title":"Cancer J"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00520-009-0723-2","article-title":". Insight in the prediction of chemotherapy-induced nausea.","volume":"18","author":"Roscoe","year":"2010","journal-title":"Support Care Cancer"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejon.2005.03.007","article-title":"Symptom experiences during chemotherapy treatment - with focus on nausea and vomiting.","volume":"10","author":"Bergkvist","year":"2006","journal-title":"Eur J Oncol Nurs"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/1097-4679(199305)49:3<349::AID-JCLP2270490308>3.0.CO;2-J","article-title":"The Chinese version of the State-Trait Anxiety Inventory: its relationship to different measures of psychological well-being.","volume":"49","author":"Shek","year":"1993","journal-title":"J Clin Psychol"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":". An inventory for measuring clinical anxiety: psychometric properties.","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1023\/B:QURE.0000018484.89711.e2","article-title":". Factors influencing health-related quality of life of Asians with anxiety disorders in Singapore.","volume":"13","author":"Luo","year":"2004","journal-title":"Qual Life Res"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0887-6185(91)90002-B","article-title":"Relationship between the beck anxiety inventory and the Hamilton anxiety rating scale with anxious outpatients.","volume":"5","author":"Beck","year":"1991","journal-title":"J Anxiety Disord"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0887-6185(93)90002-3","article-title":". Further evidence for the validity of the beck anxiety inventory with psychiatric outpatients.","volume":"7","author":"Steer","year":"1993","journal-title":"J Anxiety Disord"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/cncr.21222","article-title":". Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials.","volume":"104","author":"Gralla","year":"2005","journal-title":"Cancer"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1200\/JCO.2009.21.8511","article-title":". Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy.","volume":"27","author":"Herrstedt","year":"2009","journal-title":"J Clin Oncol"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1002\/cncr.24630","article-title":". Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy.","volume":"115","author":"Arpornwirat","year":"2009","journal-title":"Cancer"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00520-008-0545-7","article-title":". Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.","volume":"17","author":"Hesketh","year":"2009","journal-title":"Support Care Cancer"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-008-9957-9","article-title":". A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.","volume":"113","author":"Yeo","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ejca.2008.11.046","article-title":". Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy.","volume":"45","author":"Jordan","year":"2009","journal-title":"Eur J Cancer"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clon.2007.09.007","article-title":". Symptom clusters in cancer patients with brain metastases.","volume":"20","author":"Chow","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/jpm.2007.0145","article-title":". Symptom clusters in patients with cancer with metastatic bone pain.","volume":"11","author":"Hadi","year":"2008","journal-title":"J Palliat Med"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.clinph.2006.05.023","article-title":"Interpretation of the repetitive nerve stimulation test results using principal component analysis.","volume":"117","author":"Cengiz","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"R27-10-20210128","first-page":"10","article-title":"Optimal data analysis: a general statistical analysis paradigm.","volume":"1","author":"Yarnold","year":"2010","journal-title":"Optimal Data Anal"},{"key":"R28-10-20210128","first-page":"163","article-title":". Application of unsupervised learning in clinical oncology practiceexploring anxiety characteristics in chemotherapy-induced nausea and vomiting through principal variables.","volume":"2","author":"Yap","year":"2010","journal-title":"J Comput"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1081\/SAC-100002371","article-title":"Variable selection and interpretation of covariance principal components.","volume":"30","author":"Al-Kandari","year":"2001","journal-title":"Commun Stat Simul Comput"},{"key":"R32-10-20210128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00384-007-0421-9","article-title":". Gender differences in the trend of colorectal cancer incidence in Singapore, 1968-2002.","volume":"23","author":"de Kok","year":"2008","journal-title":"Int J Colorectal Dis"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201204000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:17:36Z","timestamp":1618035456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201204000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31824888a1","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}